Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) Non-Current Deferred Tax Liability (2022 - 2026)

Updated

Grace Therapeutics (GRCE) reported Non-Current Deferred Tax Liability of $604,000 for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 73.9% from $2.31 million a year earlier and down 1.3% from the prior quarter.

Analysis

Grace Therapeutics (GRCE) Non-Current Deferred Tax Liability (2022 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Grace Therapeutics posted Non-Current Deferred Tax Liability of $612,000, down 73.5% from FY2025.

  • Non-Current Deferred Tax Liability has declined for four consecutive fiscal years, with a four-year compound annual growth rate of -56.4% (FY2022 to FY2026).
  • By fiscal year, Non-Current Deferred Tax Liability came in at $2.31 million in FY2025 (-58.1%), $5.51 million in FY2024 (-24.9%), $7.35 million in FY2023 (-56.5%) and $16.89 million in FY2022.
  • The fiscal Q2 2027 figure ranks as the lowest quarterly Non-Current Deferred Tax Liability in data going back to fiscal Q4 2022.
  • Year over year, Non-Current Deferred Tax Liability has now declined in each of the last 15 quarters, with an average decline of 56.3% over the last eight quarters.
  • Across the past five years, year-over-year decline in Non-Current Deferred Tax Liability ran from 24.9% in fiscal Q4 2024 to 73.9% in fiscal Q2 2027.
  • Per Business Quant data, the three fiscal quarters before Q2 2027 came in at $612,000 (Q1 2027), $612,000 (Q4 2026) and $2.31 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Grace Therapeutics 35.10 Mn -35.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 604,000.00
Jun 30, 2026 612,000.00
Mar 31, 2026 612,000.00
Dec 31, 2025 2.31 Mn
Sep 30, 2025 2.31 Mn
Jun 30, 2025 2.31 Mn
Mar 31, 2025 2.31 Mn
Dec 31, 2024 3.33 Mn
Sep 30, 2024 3.94 Mn
Jun 30, 2024 4.79 Mn
Mar 31, 2024 5.51 Mn
Dec 31, 2023 6.40 Mn
Sep 30, 2023 6.61 Mn
Jun 30, 2023 7.06 Mn
Mar 31, 2023 7.35 Mn
Dec 31, 2022 16.22 Mn
Sep 30, 2022 16.49 Mn
Jun 30, 2022 16.65 Mn
Mar 31, 2022 16.89 Mn
API Access

Grace Therapeutics Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=GRCE&period=max&api_key=YOUR_API_KEY